Maravai LifeSciences
MRVI
MRVI
217 hedge funds and large institutions have $1.2B invested in Maravai LifeSciences in 2024 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 67 increasing their positions, 67 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 67
9.25% less ownership
Funds ownership: 111.06% → 101.81% (-9.2%)
Holders
217
Holding in Top 10
2
Calls
$2.17M
Puts
$236K
Top Buyers
| 1 | +$31M | |
| 2 | +$22.1M | |
| 3 | +$13.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.42M |
| 5 |
Morgan Stanley
New York
|
+$8.14M |
Top Sellers
| 1 | -$33.2M | |
| 2 | -$20.7M | |
| 3 | -$17.7M | |
| 4 |
Millennium Management
New York
|
-$13.7M |
| 5 |
Jennison Associates
New York
|
-$13.1M |